Women with SHBG <33.4 nmol/l had also a significantly higher NAFLD-LFS, both in unadjusted and adjusted models (p<0.0001 and p=0.001, respectively – data shown in Supplementary Tables). The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.